JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.

Payzin, Kadriye Bahriye

JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. [electronic resource] - Clinical lymphoma, myeloma & leukemia Dec 2014 - 525-33 p. digital

Publication Type: Journal Article

2152-2669

10.1016/j.clml.2014.02.013 doi


Adolescent
Adult
Aged
Aged, 80 and over
Alleles
Chronic Disease
Codon
Disease Progression
Female
Follow-Up Studies
Genotype
Humans
Janus Kinase 2--genetics
Male
Middle Aged
Mutation
Myeloproliferative Disorders--complications
Phenotype
Thrombosis--etiology
Treatment Outcome
Young Adult